08/05/2026
A proud moment for M|O|C Cancer Care as 3 of our cancer research abstracts have been selected for presentation at the ESMO TAT Asia 2026, marking another major milestone just 2 months after our abstracts were accepted for online publications by the ASCO.
ESMO TAT Asia is one of the leading oncology platforms focused on precision oncology, early drug development, and next-generation cancer therapies in the Asia-Pacific region.
Why is this significant for patients?
* Recognition of Indian cancer research and better understanding of cancer in Indian patients
* Greater inclusion of Indian/Asian clinical data in global treatment guidelines
* Improved treatment approaches tailored to India’s diverse patient population
* Access to promising experimental therapies through clinical research at no cost to eligible patients
This recognition reflects M|O|C Cancer Care’s commitment to advancing evidence-based cancer care through meaningful clinical research and improving patient outcomes.
Download research abstracts: https://shorturl.at/2Mn6G
Know more at M|O|C Cancer Care www.mocindia.co.inMOCIndia